Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Canopy Growth said on Friday it will focus on reducing costs as the pot producer struggles with a slump in weed prices from oversupply and growing expenses that led to a bigger adjusted loss in the quarter.

Canopy Growth promises to focus on cutting costs as losses grow

The U.S.-listed shares of Canopy Growth Corp. CGC, -0.66% WEED, -0.54% rocketed 16% in premarket trading Friday, after the Canada-based cannabis company reported a narrower-than-expected fiscal third-quarter loss and revenue that rose above forecasts, amid strength in business-to-consumer sales.

Canopy Growth's stock soars after narrower-than-expected loss, revenue beat

Tilray Brands

When it comes to cans, THC levels are likely to be lower than what's on the label.

Aluminum Cans May Reduce the Potency of Cannabis Beverages

CGC stock is likely to languish after its fiscal third-quarter earnings report unless it can prove it's on track to be profitable soon.
The post Earnings Preview: Analysts Expect Canopy Growth’s Revenue to Slump appeared first on InvestorPlace.

Earnings Preview: Analysts Expect Canopy Growth’s Revenue to Slump

American Water Works

Deere & Company

iShares U.S. Healthcare ETF

iShares Dow Jones U.S. ETF

JPMorgan Chase & Co

NextEra Energy

Plug Power

SPDR S&P 500 ETF Trust

Teva Pharmaceutical

Tesla

United States Steel

SPDR S&P Homebuilders ETF

Exxon Mobil

Here's your complete guide on which stocks to buy, depending on who wins the 2020 U.S. Presidential Election.

15 Stocks to Buy Based On The 2020 U.S. Presidential Election

Aphria

It's a question that needs to be asked now more than ever.

Should Investors Avoid Large-Cap Pot Stocks Altogether?

Aurora Cannabis

Cronos Group

The launch of high-margin edibles, vapes, and infused beverages isn't going according to plan.

4 Ways "Cannabis 2.0" Will Be an Early Disappointment in Canada

Should you expect the unexpected with the Canadian cannabis leader's quarterly update?

3 Potential Surprises to Watch For in Canopy Growth's Q3 Results

HEXO Corp

Scotts Miracle-Gro

After a brutal year in 2019, cannabis stocks are off to another rough start so far in 2020.

7 Cannabis Stocks To Buy, Sell And Hold

CGC stock has faded again into earnings, and cannabis stocks could see volatility ahead. But any dip is a long-term buying opportunity.

Canopy Growth Stock Remains a Long-Term Buy Ahead of Earnings

Boyd Gaming

Diageo

Altria

Raytheon

Almost regardless of what happens these days, the market pushes higher. Impeach the president?

5 Sin Stocks to Buy That May Survive a Massive Market Sell-Off

New CEO David Klein needs to limit his cash burn and save struggling Cannabis 2.0 investments in order for CGC stock to survive.
The post Canopy Growth Needs to Keep Cash High in Order to Survive appeared first on InvestorPlace.

Canopy Growth Needs to Keep Cash High in Order to Survive

CGC stock has been on the uptrend lately and this bullishness is likely to sustain. The market is getting more rational and Canopy has the resources to thrive.

3 Reasons Why Not To Weed Out Canopy Stock

Key acquisitions are expected to have significantly contributed to Canopy Growth's (CGC) top line in the fiscal third quarter

Cannabis Therapy to Drive Canopy Growth's (CGC) Q3 Earnings

And the Canadian cannabis producer can thank some people in one small Midwestern U.S. state.

The Odds That Canopy Growth's $3.4 Billion Bet Will Pay Off Are Now Better Than Ever

Earnings season may not be kind to the shareholders of either Aurora Cannabis or Canopy Growth. Here's why.

Aurora Cannabis and Canopy Growth: Avoid These 2 Pot Stocks This Week

CannTrust Holdings

There have been some big changes among the leading cannabis producers since June.

Ranking Canada's Top Marijuana Growers

With so many cannabis stocks to choose from, which ones have what it takes to break out from the crowd? Here are three with strong potential.

3 Cannabis Stocks Ready to Break Away From the Crowd

Canopy Growth Corporation (CGC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Canopy Growth Corporation (CGC) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

After plunging in 2019, CGC stock could rebound in a big way in 2020 thanks to three major growth catalysts.
The post Stick with the Recent Rally in Canopy Growth Stock appeared first on InvestorPlace.

Stick with the Recent Rally in Canopy Growth Stock

It’s best to wait for the smoke to clear with CGC stock. Until we have specifics, look for cannabis opportunities elsewhere.

Canopy Growth Stock Should Be Avoided in the Near-Term

The stock market’s love affair with Canopy Growth Corporation is over. And if you’re holding on to your shares of this one-time heartthrob in the marijuana space, then you’re facing a bitter Valentine’s Day with nothing but broken promises and heartache for your trouble.

With Earnings Looming, Sell CGC Stock Before It Breaks Your Heart

Here's what you need to know ahead of Canopy's earnings release next week.

5 Things to Know About Canopy Growth's Q3 Report

Slow growth across the medicinal cannabis sector and a high rate of cash burn are major concerns for Canopy Growth and equity dilution seems likely in 2020.
The post Canopy Growth Stock Remains Unattractive For 2020 Off High Cash Burn appeared first on InvestorPlace.

Canopy Growth Stock Remains Unattractive For 2020 Off High Cash Burn

Two Canadian pot stocks and one U.S. CBD stock are at the top of the list to keep on your radar this month.

3 Top Marijuana Stocks to Watch in February

News for Canopy Growth Stock (CGC)